AB Corporate Bond ETF Stock Price, News & Analysis
Company Description
AB Corporate Bond ETF (NASDAQ: EYEG) is a publicly traded company in the Pharmaceutical Preparations sector.
EYEG stock has declined 0.6% over the past year. Shares last traded at $35.24.
This page provides a comprehensive overview of EYEG stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
AB Corporate Bond ETF (EYEG) stock last traded at $35.24. Over the past 12 months, the stock has lost 0.6%.
Latest News
AB Corporate Bond ETF has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 4 with negative movement. Key topics include management, acquisition, conferences, clinical trial, earnings. View all EYEG news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in AB Corporate Bond ETF (EYEG) currently stands at 136 shares, down 51.6% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 70%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for AB Corporate Bond ETF (EYEG) currently stands at 1.0 days, down 69.6% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 102.0 days.
EYEG Company Profile & Sector Positioning
AB Corporate Bond ETF (EYEG) operates in the Pharmaceutical Preparations sector and is listed on the NASDAQ.